Resistant malaria.
D002648:Child; D003622:Dapsone / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D011739:Pyrimethamine / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use
D011743:Pyrimidines; D013449:Sulfonamides; D003622:Dapsone; D011739:Pyrimethamine